459 related articles for article (PubMed ID: 12190163)
1. Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study.
Khan Z; Vlodov J; Horovitz J; Jose RM; Iswara K; Smotkin J; Brown A; Tenner S
Am J Gastroenterol; 2002 Aug; 97(8):1973-7. PubMed ID: 12190163
[TBL] [Abstract][Full Text] [Related]
2. Early prediction of severe acute pancreatitis by urinary trypsinogen activation peptide.
Liu ZS; Jiang CQ; Qian Q; Sun Q; Fan LF; Ai ZL
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):285-9. PubMed ID: 14612286
[TBL] [Abstract][Full Text] [Related]
3. Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis.
Johnson CD; Lempinen M; Imrie CW; Puolakkainen P; Kemppainen E; Carter R; McKay C
Br J Surg; 2004 Aug; 91(8):1027-33. PubMed ID: 15286966
[TBL] [Abstract][Full Text] [Related]
4. APACHE system is better than Ranson system in the prediction of severity of acute pancreatitis.
Yeung YP; Lam BY; Yip AW
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):294-9. PubMed ID: 16698595
[TBL] [Abstract][Full Text] [Related]
5. What are the predictors of post-ERCP pancreatitis, and how useful are they?
Sultan S; Baillie J
JOP; 2002 Nov; 3(6):188-94. PubMed ID: 12432185
[TBL] [Abstract][Full Text] [Related]
6. Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis.
Appelros S; Petersson U; Toh S; Johnson C; Borgström A
Br J Surg; 2001 Feb; 88(2):216-21. PubMed ID: 11167870
[TBL] [Abstract][Full Text] [Related]
7. Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis.
Mayer JM; Raraty M; Slavin J; Kemppainen E; Fitzpatrick J; Hietaranta A; Puolakkainen P; Beger HG; Neoptolemos JP
Br J Surg; 2002 Feb; 89(2):163-71. PubMed ID: 11856128
[TBL] [Abstract][Full Text] [Related]
8. Hemoconcentration: an early marker of severe and/or necrotizing pancreatitis? A critical appraisal.
Lankisch PG; Mahlke R; Blum T; Bruns A; Bruns D; Maisonneuve P; Lowenfels AB
Am J Gastroenterol; 2001 Jul; 96(7):2081-5. PubMed ID: 11467635
[TBL] [Abstract][Full Text] [Related]
9. A comparison of serum trypsinogen-2 and trypsin-2-alpha1-antitrypsin complex with lipase and amylase in the diagnosis and assessment of severity in the early phase of acute pancreatitis.
Hedström J; Kemppainen E; Andersén J; Jokela H; Puolakkainen P; Stenman UH
Am J Gastroenterol; 2001 Feb; 96(2):424-30. PubMed ID: 11232685
[TBL] [Abstract][Full Text] [Related]
10. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis.
Tenner S; Fernandez-del Castillo C; Warshaw A; Steinberg W; Hermon-Taylor J; Valenzuela JE; Hariri M; Hughes M; Banks PA
Int J Pancreatol; 1997 Apr; 21(2):105-10. PubMed ID: 9209951
[TBL] [Abstract][Full Text] [Related]
11. Comparison of urine trypsinogen-2 test strip with serum lipase in the diagnosis of acute pancreatitis.
Kylänpää-Bäck ML; Kemppainen E; Puolakkainen P; Hedström J; Haapiainen R; Korvuo A; Stenman UH
Hepatogastroenterology; 2002; 49(46):1130-4. PubMed ID: 12143219
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin precursors in the prediction of severity of acute pancreatitis on the day of admission.
Ammori BJ; Becker KL; Kite P; Snider RH; Nylén ES; White JC; Larvin M; McMahon MJ
Br J Surg; 2003 Feb; 90(2):197-204. PubMed ID: 12555296
[TBL] [Abstract][Full Text] [Related]
13. Acute pancreatitis in HIV-seropositive patients: a case control study of 44 patients.
Cappell MS; Marks M
Am J Med; 1995 Mar; 98(3):243-8. PubMed ID: 7872340
[TBL] [Abstract][Full Text] [Related]
14. Trypsinogen-2 and trypsinogen activation peptide (TAP) in urine of patients with acute pancreatitis.
Lempinen M; Stenman UH; Finne P; Puolakkainen P; Haapiainen R; Kemppainen E
J Surg Res; 2003 May; 111(2):267-73. PubMed ID: 12850473
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the urinary trypsinogen-2, trypsinogen activation peptide, and the computed tomography severity index as early predictors of the severity of acute pancreatitis.
Huang QL; Qian ZX; Li H
Hepatogastroenterology; 2010; 57(102-103):1295-9. PubMed ID: 21410075
[TBL] [Abstract][Full Text] [Related]
16. Early prediction of severity in acute pancreatitis. Is this possible?
Sandberg AA; Borgström A
JOP; 2002 Sep; 3(5):116-25. PubMed ID: 12221326
[TBL] [Abstract][Full Text] [Related]
17. Rapid measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis.
Kemppainen EA; Hedström JI; Puolakkainen PA; Sainio VS; Haapiainen RK; Perhoniemi V; Osman S; Kivilaakso EO; Stenman UH
N Engl J Med; 1997 Jun; 336(25):1788-93. PubMed ID: 9187069
[TBL] [Abstract][Full Text] [Related]
18. Clinical laboratory assessment of acute pancreatitis.
Al-Bahrani AZ; Ammori BJ
Clin Chim Acta; 2005 Dec; 362(1-2):26-48. PubMed ID: 16024009
[TBL] [Abstract][Full Text] [Related]
19. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study.
Neoptolemos JP; Kemppainen EA; Mayer JM; Fitzpatrick JM; Raraty MG; Slavin J; Beger HG; Hietaranta AJ; Puolakkainen PA
Lancet; 2000 Jun; 355(9219):1955-60. PubMed ID: 10859041
[TBL] [Abstract][Full Text] [Related]
20. Early prediction of severity in acute pancreatitis using infrared spectroscopy of serum.
Petrov MS; Gordetzov AS; Kukosh MV
Pancreatology; 2007; 7(5-6):451-8. PubMed ID: 17912016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
